Showing results (2441-2450 of 45,231) with videos related to
Sort By:
Pageof 4,524
Cancer Research|September 9, 2010
Colorectal tumors are effectively eradicated by combined inhibition of {beta}-catenin, KRAS, and the oncogenic transcription factor ITF2Luca Mologni, Hafedh Dekhil, Monica Ceccon, et al.Cancer Research|September 9, 2010
Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognitionJason H Fine, Peter Chen, Aruz Mesci, et al.Cancer Research|September 9, 2010
In vivo imaging of tumor transduced with bimodal lentiviral vector encoding human ferritin and green fluorescent protein on a 1.5T clinical magnetic resonance scannerHoe Suk Kim, Hye Rim Cho, Seung Hong Choi, et al.Cancer Research|September 24, 2010
Evidence of an adaptive response targeting DNA nonhomologous end joining and its transmission to bystander cellsHolger Klammer, Munira Kadhim, George IliakisCancer Research|September 24, 2010
Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistanceHairong Huo, Pellegrino G Magro, E Christy Pietsch, et al.Cancer Research|September 24, 2010
Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanomaAndrea Anichini, Alessandra Molla, Claudia Vegetti, et al.Cancer Research|September 25, 2010
ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2Ekaterina V Kalashnikova, Alexey S Revenko, Abigael T Gemo, et al.Cancer Research|September 25, 2010
{Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironmentAjaikumar B Kunnumakkara, Bokyung Sung, Jayaraj Ravindran, et al.Cancer Research|October 7, 2010
In silico modeling and in vivo efficacy of cancer-preventive vaccinationsArianna Palladini, Giordano Nicoletti, Francesco Pappalardo, et al.Cancer Research|October 7, 2010
Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha primingRaphaëlle Romieu-Mourez, Moïra François, Amanda Abate, et al.Pageof 4,524